Sudarshan Pharma Industries Limited disclosed that promoter Mr. Hemal Vasantrai Mehta has pledged 0.83% of the company's total share capital to secure a personal loan. The encumbrance involves 20,00,000 shares and was created on June 3, 2026, in favor of Mr. Kirit Ratilal Shah. This disclosure, submitted to BSE Limited, rectifies previous errors regarding post-event holding tallies and provides the specific reason for the pledge, which was initially omitted.

The revised filing addresses queries raised by the exchange regarding the original submission made on June 5, 2026. Specifically, the company corrected the format to comply with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as per the circular effective August 5, 2015. The document confirms that the pledge was a creation of encumbrance rather than a release or invocation.

Details of Encumbrance

The following table outlines the specifics of the share pledge disclosed by the promoter:

Prior to this event, the promoter had no encumbered shares. Following the creation of the pledge, the total number of encumbered shares stands at 20,00,000. The disclosure was signed by Hemal Mehta, Promoter, and countersigned by Nirav Shah, Company Secretary & Compliance Officer, on July 14, 2026.

Sudarshan Pharma Industries Ltd shareholders have approved the migration of the company's equity shares from the SME Platform of BSE Limited to the Main Board of BSE Limited. The resolution, passed via a postal ballot conducted from 26 May 2026 to 24 June 2026, received 100% of the votes polled. This move allows the company to transition from the SME segment to the main board, potentially enhancing liquidity and visibility for its shares.

In a parallel decision, shareholders sanctioned an application for the listing and trading of the company's shares on the Main Board of National Stock Exchange of India Limited. This resolution also secured unanimous approval from the votes cast. The dual approvals facilitate the company's shift to the main trading platforms of both premier stock exchanges in India.

The postal ballot process also saw the appointment of Mr. Sanat Bhat (DIN: 08059016) as an Independent Director for a period of 5 years. The resolution received 1,980,110 votes in favour, representing 100% of the total votes polled on this item. No votes were cast against the appointment.

Furthermore, Dr. Vinay Pandey (DIN: 10084203) was appointed as a Non-Executive Non-Independent Director, liable to retire by rotation. This ordinary resolution was passed with the support of 1,980,110 votes, constituting the entirety of the votes polled for this specific agenda item.

The voting results were submitted to BSE Limited pursuant to Regulation 44(3) of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. The table below summarizes the voting outcomes for the key resolutions.